A methylxanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Mechanistically, theophylline acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Theophylline is marketed under several brand names such as Uniphyl and Theochron, and it is indicated mainly for asthma, bronchospasm, and COPD.
Synonyms
Theophylline anhydrous
1,3-dimethyl-7H-purine-2,6-dione
Theophyllin
Theophylline
1,3-dimethylxanthine
Theophylline, anhydrous
Theophylline sodium glycinate
Teofilina
Brand Names
Theolair SR Tab 250mg
Slo-bid 300
Pulmophylline Elx
Theo-dur 100 mg
Theochron Srt 200mg
Theo-SR 300 Srt 300mg
Senophylline
Theochron Srt 300mg
Theophylline 0.8mg/ml In 5% Dextrose Inj
Theophylline Anhydrous
Theophylline Extended Release
Theophylline
Theophylline 4mg and 5% Dextrose Inj
Theolair Tab 250mg
Quibron-T
Theophylline Elixir
Theophylline(Anhydrous)
PMS-theophylline Elixir
Theophylline Elx
Theo-dur 450 mg
Theophylline Rougier Elixir
Apo-theo ER
Tedral Tab
Theolair SR Tab 500mg
Theophylline (Anhydrous)
Theo-dur 200 mg
Theolair Tab 125mg
Ratio-theo-bronc
Theophylline in Dextrose
Quibron T/SR
Slo-bid 200
Elixophyllin
Teva-theophylline SR
Theo-dur 300 mg
Idm Tab
Theolair SR Tab 200mg
Aa-theo LA
Slo-bid 50
Theochron Srt 100mg
Theophylline 1.6mg and 5% Dextrose Inj
Theo-24
Theophylline 80mg/15ml
Theolair SR Tab 300mg
Uniphyl
Slo-bid 100
Theolair
Quibron T SR Tab 300mg
Theo ER
Elixir De Theophylline
I D M Expectorant Tab
Theophylline 0.8mg and 5% Dextrose Inj
Indication
For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.
Categories
Agents that reduce seizure threshold
Alkaloids
Anti-Asthmatic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Cytochrome P-450 CYP1A2 Substrates
Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
Cytochrome P-450 CYP2C8 Substrates
Cytochrome P-450 CYP2D6 Substrates
Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
Cytochrome P-450 CYP2E1 Substrates
Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index
Cytochrome P-450 CYP3A Substrates
Cytochrome P-450 CYP3A4 Substrates
Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682